CHD1 and prostate neoplasm: In addition to confirming the presence of recurrent CaP genomic alterations such as TMPRSS2-ERG fusion, PTEN and CHD1 deletions, a novel recurrent deletion of LSAMP gene on chromosome 3q13.31 was found to more prevalent in prostate tumors from AA men compared to CA men (26% vs. 7%).